Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Rhode Island Hospital |
---|---|
Information provided by: | Rhode Island Hospital |
ClinicalTrials.gov Identifier: | NCT00237406 |
This study is designed to test whether a telephone call-in program is a feasible way to collect mood and drug-related information in individuals enrolled in a methadone maintenance program.
Condition | Intervention | Phase |
---|---|---|
Opioid-Related Disorders |
Procedure: interactive voice response |
Phase III |
Study Type: | Observational |
Study Design: | Prospective |
Official Title: | Interactive Voice Response for Methadone Patients |
Estimated Enrollment: | 50 |
Study Start Date: | January 2006 |
Study Completion Date: | October 2006 |
Participants will complete a baseline interview and a follow-up interview at 5-weeks post-baseline. Two-thirds of the participants will be randomized into the telephone call-in group, and will be asked to complete daily, 10-minute, telephone interviews. To complete these interviews, participants will call into a toll-free telephone interview system with a unique and private Study ID number, and answers questions by using the telephone key pad. Questions during both the face-to-face interviews and the telephone interviews will assess mood, sleep, treatment utilization and drug-related experiences. Participants will be compensated for their time.
Comparison(s): Participants randomized into the telephone component of the study as compared to participants in the interview-only component of the study.
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Rhode Island | |
Rhode Island Hospital | |
Providence, Rhode Island, United States, 02903 |
Principal Investigator: | Michael D Stein, MD | Rhode Island Hospital |
Study ID Numbers: | 4065-05 |
Study First Received: | October 11, 2005 |
Last Updated: | December 17, 2007 |
ClinicalTrials.gov Identifier: | NCT00237406 |
Health Authority: | United States: Institutional Review Board |
IVR, methadone methadone maintenance |
Naphazoline Oxymetazoline Methadone Guaifenesin Phenylephrine |
Mental Disorders Substance-Related Disorders Disorders of Environmental Origin Phenylpropanolamine Opioid-Related Disorders |
Respiratory System Agents Sensory System Agents Therapeutic Uses Physiological Effects of Drugs Central Nervous System Depressants Narcotics |
Peripheral Nervous System Agents Analgesics Antitussive Agents Central Nervous System Agents Analgesics, Opioid Pharmacologic Actions |